| ²é¿´: 1731 | »Ø¸´: 25 | ||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û12´Î£¬×÷ÕßleigenÔö¼Ó½ð±Ò 10 ¸ö | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
[×ÊÔ´]
Ó¹úÇìËÍThe Practice of Medicinal Chemistry (Third Edition) ±¾ÌûÍ£Ö¹¸üÐÂ
|
||
|
¡¾±¾ÌùÊ×·¢ÓÚchem8er¡¿ http://chem8.org/bbs/thread-19425-1-1.html ![]() ÕâÊÇÔÚÒ©ÎﻯѧÁìÓò±»³ÉΪʥ¾£¨Medicinal Chemists's Bible£©µÄÒ»±¾ºÃÊ飡¸Õ³ö×îÐÂÖ®µÚÈý°æ£¡ ǡֵ¹úÇ죬Ãâ·ÑËͳö´ËÊ飬ÒÔ÷ÏËùÓÐemucher£¡ µÃµ½Ò»±¾µç×ÓÊé»òÐí²»ÄÑ£¬ÄѵÄÊÇÒªÇÚ¶Áϸ¶Á£¬ÕæÕý´ÓÊéÖÐÓÐËùµÃ£¬²»ÒªÈÃËüÖ»ÊǾ²¾²µØÌÉÔÚÄãµÄÓ²ÅÌÖУ¬»òÕßÊǵ±ÓëËûÈË̸ÆðʱֻƽÌíÒ»¾ä¡°ÎÒÓÐÕâÊéµÄµç×Ó°æµÄ¡±°ÕÁË£¡ ¸Ã°æÈÔÈ»º¸ÇÁËÒ©ÎﻯѧÑо¿ÁìÓò¡°´ÓÍ·µ½½Å¡±µÄ¸ÅÄî½éÉÜ¡¢ÀúÊ··¢Õ¹ÓëÑо¿ÊµÀý£¬¸üÐÂÁË×î½ü5ÄêµÄÑо¿½á¹û£¬Ôö¼ÓÁË11Õ½ڵÄÐÂÄÚÈÝ£¬ÄÚÈݺ¸ÇÒ©ÎïÑо¿µÄ´«Í³·½·¨ºÍ×îм¼Êõ¡£Óëǰ¼¸°æ±¾Ïà±È£¬±¾°æµÄÒ»¸öÖ÷Òª±ä»¯¾ÍÊÇÈ«Êé·Ö³ÉÁË8¸ösection£¬ÓÐÖ÷±àºÍÁíÍâ7¸ösection editors¸÷×Ô¸ºÔðÒ»¸ösection£»ÁíÒ»¸öÖ÷ÒªµÄ±ä»¯¾ÍÊÇÈ«ÊéΪ²ÊÉ«£¬ÕâΪ¸ÃÊéÔöÉ«²»ÉÙ£¬Ê¹ÎÒÃÇÔÚ»ñȡ֪ʶµÄ¹ý³ÌÖÐÓÐÁËÄѵõÄÏíÊÜ£¡¿´Ò»±¾²ÊÉ«ÄÚÈݵÄÊéºÍ¿´Ò»±¾È«ÊÇÃÜÃÜÂéÂéÎÄ×ÖµÄÊéµÄÐÄÇéºÍЧ¹ûÖ®´óÏྶͥ£¬Ïë±Ø´ó¼Ò¶¼ÉîÓÐÌå»á! ¸ÃÊé²»½öÊdzõʶҩÎﻯѧÕßµÄÒ»±¾ºÜºÃµÄÈëÃÅÊé¼®£¬Ò²ÊÇÒ©ÎﻯѧÑо¿Õß°¸Í·±Ø±¸Ö®Ê飬¶ÔÓÚÕû¸öÉúÃü¿ÆÑ§ÁìÓòµÄѧÕß¶øÑÔÒ²ÊÇÒ»±¾ÄѵõĺÃÊ飬¶ÔÓÚ·ÇרҵÁìÓòÈËʶøÑÔÊéÖеIJ»ÉÙÄÚÈÝÒ²ÊǺÜÓмÛÖµµÄ£¡ δÉèÖýð±ÒÏÞÖÆ£¬Ãâ·ÑÏÂÔØ£¬×÷Ϊ¹úÇì¼Ñ½ÚµÄÒ»·ÝºØÀñ°É£¡ http://www.box.net/shared/hdxeo0g7so ÃÜÂë www.chem8.org ±¾ÏÂÔØµØÖ·³¤ÆÚÓÐЧ£¬Èç¹ûËÒª´«ÓÚ¹úÄÚÏÂÔØµØÖ·£¬ÇëÔÚ±¾ÌûÏ·½¸úÌû£¬ÎðÖØ¿ªÐÂÌû»òÇóÖú£¬ÉîÎªÖØ¸´·¢ÌûÄÕ£¬ËüÒÑ´ó´óÓ°ÏìÁËemuchµÄ°æÃæÖÊÁ¿£¡ Çë°æÖ÷ÐÖú°É£¡ ±¾ÌûÍ£Ö¹¸üУ¬ÇëÖÁÁíÒ»Ìûhttp://muchong.com/bbs/viewthread.php?tid=985332²é¿´½øÒ»²½ÐÅÏ¢£¡ ÒÔÏÂΪ¸ÃÊéĿ¼£º The Practice of Medicinal Chemistry (Third Edition) By Camille Wermuth, Prestwick Chemical, Illkirch, France Publisher: Academic Press Number Of Pages: 982 Publication Date: 2008-07-23 ISBN-10 / ASIN: 0123741947 ISBN-13 / EAN: 9780123741943 Binding: Hardcover Description Now in its third edition, this classic reference is the one-stop-shop for information on the foundations of medicinal chemistry for pharmaceutical researchers who are involved in drug development discovery but who do not have a background in medicinal chemistry. Wermuth aids pharmaceutical researchers and chemists in making faster, more accurate identifications of the active substances that could potentially treat the disorder they are researching. New chapters on Drug Absorption & Transport give pharmaceutical scientists information on how potential drugs can move through the drug discovery/development phases more quickly. This third edition still stands as the only source for practical aspects of medicinal chemistry by focusing on the daily problems met by the medicinal chemist in drug discovery. Audience Pharmaceutical researchers in drug discovery, chemists Table of Contents Biography, Pages xxv-xxvi Contributors, Pages xxix-xxxiii Preface to the First Edition, Pages xxxv-xxxvi Preface to the Second Edition, Pages xxxvii-xxxviii Preface to the Third Edition, Page xxxix Part I: General Aspects of Medicinal Chemistry Chapter 1 - A History of Drug DiscoveryFrom first steps of chemistry to achievements in molecular pharmacology, Pages 1-62, François Chast Chapter 2 - Medicinal ChemistryDefinitions and Objectives, Drug Activity Phases, Drug Classification Systems, Pages 63-72, Peter Imming Chapter 3 - Measurement and Expression of Drug Effects, Pages 73-84, Jean-Pierre Nowicki, Bernard Scatton Chapter 4 - Molecular Drug Targets, Pages 85-105, Jean-Pierre Gies, Yves Landry Chapter 5 - Drug Targets, Target identification, Validation and Screening, Pages 106-121, Kenton H. Zavitz, Paul L. Bartel, Adrian N. Hobden Part II: Lead Compound Discovery Strategies Chapter 6 - Strategies in the Search for New Lead Compounds or Original Working Hypotheses, Pages 123-143, Camille G. Wermuth Chapter 7 - High-Throughput Screening and Drug Discovery, Pages 144-158, John R. Proudfoot Chapter 8 - Natural Products as Pharmaceuticals and Sources for Lead Structures, Pages 159-186, David J. Newman, Gordon M. Cragg, David G. I. Kingston Chapter 9 - Biology Oriented Synthesis and Diversity Oriented Synthesis in Compound Collection Development, Pages 187-209, Kamal Kumar, Stefan Wetzel, Herbert Waldmann Chapter 10 - In Silico ScreeningHit Finding from Database Mining, Pages 210-227, Thierry Langer, Sharon D. Bryant Chapter 11 - Fragment-Based Drug Discovery, Pages 228-243, Bennett T. Farmer, Allen B. Reitz Chapter 12 - Lead-Likeness and Drug-Likeness, Pages 244-254, Alex Polinsky Chapter 13 - Web AlertUsing the Internet for Medicinal Chemistry, Pages 255-272, David Cavalla Part III: Primary Exploration of Structure¨CActivity Relationships Chapter 14 - Molecular Variations in Homologous SeriesVinylogues and Benzologues, Pages 273-289, Camille G. Wermuth Chapter 15 - Molecular Variations Based on Isosteric Replacements, Pages 290-342, Paola Ciapetti, Bruno Giethlen Chapter 16 - Ring Transformations, Pages 343-362, Christophe Morice, Camille G. Wermuth Chapter 17 - Conformational Restriction and/or Steric Hindrance in Medicinal Chemistry, Pages 363-379, Andr¨¦ Mann Chapter 18 - Homo and Heterodimer Ligands: the Twin Drug Approach, Pages 380-414, Jean-Marie Contreras, Wolfgang Sippl Chapter 19 - Application Strategies for the Primary Structure¨CActivity Relationship Exploration, Pages 415-427, Camille G. Wermuth Part IV: Substituents and Functions: Qualitative and Quantitative Aspects of Structure¨CActivity Relationships Chapter 20 - Substituent Groups, Pages 429-463, Patrick Bazzini, Camille G. Wermuth Chapter 21 - The Role of Functional Groups in Drug¨CReceptor Interactions, Pages 464-480, Laurent Schaeffer Chapter 22 - Compound Properties and Drug Quality, Pages 481-490, Christopher A. Lipinski Chapter 23 - Quantitative Approaches to Structure¨CActivity Relationships, Pages 491-513, Han van de Waterbeemd, Sally Rose Part V: Spatial Organization, Receptor Mapping and Molecular Modeling Chapter 24 - OverviewThe Search for Biologically Useful Chemical Space, Pages 515-520, David J. Triggle Chapter 25 - Pharmacological Space, Pages 521-532, Andrew L. Hopkins Chapter 26 - Optical Isomerism in Drugs, Pages 533-548, Camille G. Wermuth Chapter 27 - Multi-target DrugsStrategies and Challenges for Medicinal Chemists, Pages 549-571, Richard Morphy, Zoran Rankovic Chapter 28 - Pharmacophore Identification and Pseudo-Receptor Modeling, Pages 572-586, Wolfgang Sippl Chapter 29 - 3D Quantitative Structure¨CProperty Relationships, Pages 587-604, Thierry Langer, Sharon D. Bryant Chapter 30 - Protein Crystallography and Drug Discovery, Pages 605-634, Jean-Michel Rondeau, Herman Schreuder Part VI: Chemical Modifications Infl uencing the Pharmacokinetic Properties Chapter 31 - Physiological Aspects Determining the Pharmacokinetic Properties of Drugs, Pages 635-654, Koen Boussery, Frans M. Belpaire, Johan Van de Voorde Chapter 32 - Biotransformation Reactions and Their Enzymes, Pages 655-673, Bernard Testa Chapter 33 - Biotransformations Leading to Toxic MetabolitesChemical Aspect, Pages 674-696, Anne-Christine Macherey, Patrick M. Dansette Chapter 34 - Drug Transport Mechanisms and their Impact on the Disposition and Effects of Drugs, Pages 697-710, Jean-Michel Scherrmann Chapter 35 - Strategies for Enhancing Oral Bioavailability and Brain Penetration, Pages 711-720, Brian C. Shook, Paul F. Jackson Chapter 36 - Designing Prodrugs and Bioprecursors, Pages 721-746, Camille G. Wermuth Part VII: Pharmaceutical and Chemical Means to Solubility and Formulation Problems Chapter 37 - Preparation of Water-Soluble Compounds Through Salt Formation, Pages 747-766, Michael J. Bowker, P. Heinrich Stahl Chapter 38 - Preparation of Water-Soluble Compounds by Covalent Attachment of Solubilizing Moieties, Pages 767-785, Camille G. Wermuth Chapter 39 - Drug Solubilization with Organic Solvents, or Using Micellar Solutions or Other Colloidal Dispersed Systems, Pages 786-812, Michael J. Bowker, P. Heinrich Stahl Chapter 40 - Improvement of Drug Properties by Cyclodextrins, Pages 813-840, Kaneto Uekama, Fumitoshi Hirayama Chapter 41 - Chemical and Physicochemical Approaches to Solve Formulation Problems, Pages 841-853, Camille G. Wermuth Part VIII: Development of New Drugs: Legal and Economic Aspects Chapter 42 - Discover a Drug Substance, Formulate and Develop It to a Product, Pages 855-866, Bruno Galli, Bernard Faller Chapter 43 - Drug Nomenclature, Pages 867-877, R.G. Balocco Mattavelli, J.C. Dong, S. Lasseur, S. Kopp Chapter 44 - Legal Aspects of Product ProtectionWhat a Medicinal Chemist Should Know About Patent Protection, Pages 878-893, Maria Souleau Chapter 45 - The Consumption and Production of Pharmaceuticals, Pages 894-921, Bryan G. Reuben Index, Pages 923-942 http://www.sciencedirect.com/science/book/9780123741943 [ Last edited by leigen on 2008-10-1 at 12:54 ] |
» ²ÂÄãϲ»¶
²ÄÁϵ÷¼Á
ÒѾÓÐ11È˻ظ´
295²ÄÁϹ¤³Ìר˶Çóµ÷¼Á
ÒѾÓÐ18È˻ظ´
081200-11408-276ѧ˶Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ10È˻ظ´
²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
²ÄÁÏר˶322·Ö
ÒѾÓÐ10È˻ظ´
311Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
0856£¬269·ÖÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸ ÄϾ©Óʵç´óѧ 288·Ö ²ÄÁÏ¿¼ÑÐ Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
085602»¯Ñ§¹¤³Ì268·Ö¶×µ÷¼Á
ÒѾÓÐ8È˻ظ´
10Â¥2008-09-30 10:20:58
¡ï¡ï¡ï ÈýÐǼ¶,Ö§³Ö¹ÄÀø
¡ï ¡ï
tianruibencao(½ð±Ò+2,VIP+0):ÎÒÊÔÊÔ½¨ÒéÒ»ÏÂ
tianruibencao(½ð±Ò+2,VIP+0):ÎÒÊÔÊÔ½¨ÒéÒ»ÏÂ
| ºÃÊ飬¸Ðл·ÖÏí£¬¸öÈËÈÏΪ£¬°æÖ÷¿ÉÒÔ°ÑÒÔÍùµÄͼÊé×ÊÔ´ÕûÀíһϺóÖÃÓÚרÃŵİå¿é¹©´ó¼ÒÏÂÔØ£¬·½±ã´ó¼Ò²éѯºÍʹÓã¬Èç¹ûÌå»ýÌ«´ó¿ÉÒÔ¿¼ÂǵÚÈý·½¿Õ¼ä£¬ÉèÖÃÃÜÂ룬ȻºóÎÒÃÇ¿ÉÒÔÓýð±Ò»»ÃÜÂ룡ÏÖÔÚµÄÌû×Óȷʵ²»Ò×ѰÕÒÊé¼®£¡ |
2Â¥2008-09-29 17:22:01
4Â¥2008-09-29 17:55:31
5Â¥2008-09-29 19:07:51
¼òµ¥»Ø¸´
wanggj1236Â¥
2008-09-29 20:57
»Ø¸´




wbcg_1312Â¥
2008-09-30 12:03
»Ø¸´


¸Ðл·ÖÏí















»Ø¸´´ËÂ¥




